Detalles de la búsqueda
1.
Pazopanib in Locally Advanced or Metastatic Renal Cell Carcinoma: Results of a Randomized Phase III Trial.
J Clin Oncol
; 41(11): 1957-1964, 2023 04 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37018920
2.
Biosimilar Versus Originator Pegfilgrastim for Preventing Chemotherapy-Induced Neutropenia: A Phase III Randomized, Multicenter, Evaluator-Blinded, Noninferiority Study.
JCO Glob Oncol
; 8: e2100276, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-35324270
3.
A Phase II Randomized Study of Lapatinib Combined With Capecitabine, Vinorelbine, or Gemcitabine in Patients With HER2-Positive Metastatic Breast Cancer With Progression After a Taxane (Latin American Cooperative Oncology Group 0801 Study).
Clin Breast Cancer
; 16(1): 38-44, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26642810
4.
A randomised, double-blind phase III study of pazopanib in patients with advanced and/or metastatic renal cell carcinoma: final overall survival results and safety update.
Eur J Cancer
; 49(6): 1287-96, 2013 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-23321547
5.
Phase III, open-label, randomized study comparing concurrent gemcitabine plus cisplatin and radiation followed by adjuvant gemcitabine and cisplatin versus concurrent cisplatin and radiation in patients with stage IIB to IVA carcinoma of the cervix.
J Clin Oncol
; 29(13): 1678-85, 2011 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-21444871
6.
Phase II, open-label study of pazopanib or lapatinib monotherapy compared with pazopanib plus lapatinib combination therapy in patients with advanced and recurrent cervical cancer.
J Clin Oncol
; 28(22): 3562-9, 2010 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-20606083
7.
Pazopanib in locally advanced or metastatic renal cell carcinoma: results of a randomized phase III trial.
J Clin Oncol
; 28(6): 1061-8, 2010 Feb 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-20100962
Resultados
1 -
7
de 7
1
Próxima >
>>